Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
AbstractThe two main subsets of nonalcoholic fatty liver disease (NAFLD) include: (1) nonalcoholic fatty liver (NAFL), the more common and non-progressive subtype; and (2) nonalcoholic steatohepatitis (NASH), the less common subtype, which has the potential to progress to advanced liver damage. Current treatment strategies have focused on lifestyle management of modifiable risk factors, namely weight, and on the optimization of the management of individual components of metabolic syndrome. Various hypothetical pathogenic mechanisms have been proposed, leading to the development of novel drugs with the potential to effectively treat patients with NASH. Numerous clinical trials are ongoing, utilizing these experimental drugs and molecules targeting specific mechanistic pathway(s) to effectively treat NASH. Some of these mechanistic pathways targeted by experimental pharmacologic agents include chemokine receptor 2 and 5 antagonism, inhibition of galectin-3 protein, antagonism of toll-like receptor 4, variation of fibroblast growth factor 19, agonism of selective thyroid hormone receptor-beta, inhibition of apoptosis signal-regulating kinase 1, inhibition of acetyl-coenzyme A carboxylase, agonism of farnesoid X receptor, antibodies against lysl oxidase-like-2, and inhibition of inflammasomes. Emerging data are promising and further updates from ongoing clinical trials are eagerly awaited. View Full-Text
Share & Cite This Article
Dibba, P.; Li, A.A.; Perumpail, B.J.; John, N.; Sallam, S.; Shah, N.D.; Kwong, W.; Cholankeril, G.; Kim, D.; Ahmed, A. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases 2018, 6, 83.
Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases. 2018; 6(3):83.Chicago/Turabian Style
Dibba, Pratima; Li, Andrew A.; Perumpail, Brandon J.; John, Nimy; Sallam, Sandy; Shah, Neha D.; Kwong, Waiyee; Cholankeril, George; Kim, Donghee; Ahmed, Aijaz. 2018. "Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD." Diseases 6, no. 3: 83.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.